Industrializing High-Throughput Glycoproteomics Using AI for Clinical Use
April 26th 2022Aberrant glycosylation of proteins has been implicated in key steps of disease biology, including the hallmarks of cancer as well as inflammation cascades associated with autoimmunity and aging. InterVenn Biosciences harnesses the predictive powers of artificial intelligence combined with cutting edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome.
Oligonucleotide Purification and Characterization - Tips for Success
March 30th 2022Wednesday, March 30th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Applying the appropriate tools for oligonucleotide purification and subsequent analysis is a unique challenge requiring application specific solutions. Join Drs. Anne Blackwell and Matthew L. Turner of Agilent Technologies for tips on oligonucleotide analysis and purification with Agilent’s suite of Bio LC solutions.
Glycomics/Glycoproteomics for Biopharmaceutical and Biotechnology Industries
March 16th 2022Wednesday, March 16th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Please join us for a series of three intense investigations into the practicalities required to define, identify, and explore the functions of important biological molecules including glycans, monoclonal antibodies, and oligonucleotides. We outline cutting edge and mainstay analytic tools and protocols, with multiple case studies and practical examples from world leading experts.
Mitigate Risk, Increase Speed & Reduce Complexity with Customized Single-Use Systems
February 22nd 2022Tuesday, February 22, 2022 at 11am EST Hear from Parker Hannifin’s experts on how they are mitigating risk, while accelerating timelines, with open architecture and greater processing flexibility using custom single-use systems for vaccines, antibodies, therapeutics, and gene and cell therapies.